DE69824090D1 - Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen - Google Patents

Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen

Info

Publication number
DE69824090D1
DE69824090D1 DE69824090T DE69824090T DE69824090D1 DE 69824090 D1 DE69824090 D1 DE 69824090D1 DE 69824090 T DE69824090 T DE 69824090T DE 69824090 T DE69824090 T DE 69824090T DE 69824090 D1 DE69824090 D1 DE 69824090D1
Authority
DE
Germany
Prior art keywords
formula
compound
chem
signifies
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69824090T
Other languages
English (en)
Other versions
DE69824090T2 (de
Inventor
Paul Spurr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69824090D1 publication Critical patent/DE69824090D1/de
Application granted granted Critical
Publication of DE69824090T2 publication Critical patent/DE69824090T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/08Preparation by ring-closure
    • C07D213/09Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles
    • C07D213/10Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles from acetaldehyde or cyclic polymers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69824090T 1997-08-19 1998-08-10 Verfahren zur Herstellung von 2,5-disubstituierter Pyridine Expired - Lifetime DE69824090T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97114269 1997-08-19
EP97114269 1997-08-19

Publications (2)

Publication Number Publication Date
DE69824090D1 true DE69824090D1 (de) 2004-07-01
DE69824090T2 DE69824090T2 (de) 2005-07-07

Family

ID=8227241

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69824090T Expired - Lifetime DE69824090T2 (de) 1997-08-19 1998-08-10 Verfahren zur Herstellung von 2,5-disubstituierter Pyridine

Country Status (10)

Country Link
US (1) US6080866A (de)
EP (1) EP0897914B1 (de)
JP (1) JP3025239B2 (de)
KR (1) KR100275663B1 (de)
CN (1) CN1103335C (de)
AT (1) ATE267808T1 (de)
CA (1) CA2245169C (de)
DE (1) DE69824090T2 (de)
DK (1) DK0897914T3 (de)
ES (1) ES2221696T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US6417360B1 (en) 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
ZA200002318B (en) * 1999-05-22 2000-11-16 Actelion Pharmaceuticals Ltd Aqueous pharmaceutical composition.
ES2621018T3 (es) * 2007-02-19 2017-06-30 Marine Polymer Technologies, Inc. Composiciones hemostáticas y regímenes terapéuticos
MX342912B (es) 2010-04-15 2016-10-19 Marine Polymer Tech Inc Aplicaciones antibacterianas de nanofibras de poli-n-acetilglucosamina.
US20140127310A1 (en) 2011-04-15 2014-05-08 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acetylglucosamine nanofibers
KR20230104232A (ko) 2020-11-05 2023-07-07 이도르시아 파마슈티컬스 리미티드 클라조센탄 디소듐 염의 안정한 결정성 수화물
TW202329952A (zh) 2021-12-17 2023-08-01 瑞士商愛杜西亞製藥有限公司 克拉生坦(clazosentan)二鈉鹽之製備方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571683B2 (en) * 1984-05-23 1988-04-21 Zeneca Ag Products Inc. 2-substituted-5-methylpyridines from methylcyclobutane- carbonitrile, valeronitrile and pentenonitrile intermediates
DE4223013A1 (de) * 1992-07-13 1994-01-20 Bayer Ag Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen
US5837708A (en) * 1994-11-25 1998-11-17 Hoffmann-La Roche Inc. Sulphonamides
CA2162630C (en) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
TW313568B (de) * 1994-12-20 1997-08-21 Hoffmann La Roche

Also Published As

Publication number Publication date
US6080866A (en) 2000-06-27
CN1103335C (zh) 2003-03-19
EP0897914A1 (de) 1999-02-24
KR19990023680A (ko) 1999-03-25
CA2245169A1 (en) 1999-02-19
JPH11116554A (ja) 1999-04-27
ATE267808T1 (de) 2004-06-15
ES2221696T3 (es) 2005-01-01
DK0897914T3 (da) 2004-09-27
EP0897914B1 (de) 2004-05-26
KR100275663B1 (ko) 2000-12-15
CN1210105A (zh) 1999-03-10
JP3025239B2 (ja) 2000-03-27
CA2245169C (en) 2004-08-10
DE69824090T2 (de) 2005-07-07

Similar Documents

Publication Publication Date Title
DK1254883T3 (da) Fremgangsmåde til fremstilling af substitueret 1,1,1-trifluoro-3-butene-2-oner
DE69029334T2 (de) Verfahren zur Herstellung von Alkoxyiminoacetamid-Derivaten und ein Zwischenproduckt dafür
DK0733621T3 (da) Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse
DK539589A (da) Fremgangsmaade til fremstilling af 3-oxo-4-azasteroider
DE69824090D1 (de) Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen
GR3003776T3 (de)
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
TW357056B (en) Herbicides
ATE115567T1 (de) Verfahren zur herstellung von halogensulfonyl- substituierten pyridinen.
DE69119714D1 (de) Verfahren zur Herstellung von Benzylphthalazinonderivaten und von deren Salzen
DK0953564T3 (da) Fremgangsmåde til fremstilling af en 2-cyanobiphenylforbindelse
DK0412529T3 (da) Hidtil ukendte imidazolderivater, fremgangsmåde til fremstilling deraf og midler mod mavesår indeholdende disse
DE69733716D1 (de) Verfahren zur herstellung von imidazolderivaten
DK0662475T3 (da) Fremgangsmåde til fremstilling af 2-perfluoralkyl-3-oxazolin-5-on.
PL347503A1 (en) Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols
DE69706504D1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3-cyclobuten-1,2-dion
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
DK0644183T3 (da) Fremgangsmåde til fremstilling af N-alkylacetamider

Legal Events

Date Code Title Description
8364 No opposition during term of opposition